Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 685 of 6351
-
New hope for frail AML patients: less toxic drug combo shows promise
Disease control CompletedThis study aims to evaluate the efficacy and safety of selinexor-based chemotherapy-sparing regimens (including chemotherapy-free or dose-reduced approaches) in optimizing therapeutic strategies for treatment-naïve acute myeloid leukemia patients deemed unfit for intensive induct…
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a new pill tame eye inflammation when others fail?
Disease control OngoingUpadacitinib sustained-release tablets have not yet been approved for the treatment of uveitis. The current use falls under the category of "off-label medication", which means providing patients with potentially beneficial treatment options in the absence of formal approval. Base…
Phase 4 • Sponsor: Tianjin Medical University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New blood filter could save lives in septic shock
Disease control By invitation onlyThere is a lack of evidence in the efficacy of extracorporeal blood purification (EBP) to reduce the mortality rate in septic shock. We have designed the EABPSS (Efficacy of Adaptive Blood Purification for Septic Shock) study to confirm whether adaptive blood purification (ABP) i…
Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Routine EEGs may hold hidden clues to childhood epilepsy — a new analysis method is put to the test
Diagnosis CompletedThe goal of this retrospective study is to validate a set of computational biomarkers (BioEP) for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy. The main objectives are: Primary: To validate a set of c…
Sponsor: Neuronostics Ltd • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
Could giving heart drug earlier save more lives?
Disease control Recruiting nowThe primary objective of this pilot, pragmatic stepped-wedge cluster randomized trial is to evaluate if a modified cardiac arrest treatment algorithm calling for the administration of the initial amiodarone dose one 2-minute cycle earlier than current guidelines (during the same …
Phase 3 • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug cocktail aims to tackle tough lymphoma
Disease control Recruiting nowThis is a multicenter, open-label, non-randomized, multi-cohort study to evaluate the efficacy and safety of linperlisib combined with cyclophosphamide, prednisone, and thalidomide (CPT) regimen in the treatment of relapsed and/or refractory non-Hodgkin lymphoma.
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Stomach cancer trial combines chemo with Bacteria-Fighting treatment
Disease control Recruiting nowThis study focuses on patients with H. pylori-positive resectable locally advanced adenocarcinoma of the gastric and oesophagogastric junction. It evaluates the perioperative oxaliplatin with S-1 (SOX) combined H. pylori eradication versus oxaliplatin with S-1 in the management o…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart rhythm fix may also repair leaky valve: scientists build prediction model
Knowledge-focused By invitation onlyMitral Regurgitation (MR) is the most prevalent type of valvular heart disease in clinical practice, with an average prevalence of approximately 1% in populations with moderate-to-severe or worse MR, which increases significantly with age. Functional MR (FMR) is one subtype of MR…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
Symptom relief Recruiting nowThis study is to see Osteopathic Manipulative Therapy, or OMT, can aid in treating patients being seen for respiratory illness and associated symptoms. The hypothesis is that the addition of OMT therapy, alongside other standard care (such as a medication), can help lessen patien…
Sponsor: Geisinger Clinic • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can 3D ultrasound spot dangerous placenta conditions better?
Diagnosis CompletedPlacenta Accreta spectrum is a major obstetric disease nowadays. Different methods are used for antenatal diagnosis. In our study, investigators are aiming to compare 2 common ways for diagnosis, i.e; 3D Ultrasound and 2D with color Doppler.
Sponsor: Assiut University • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowTo evaluate the initial efficacy and safety of neoadjuvant low-dose interval radiotherapy combined with tirelizumab and SOX chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma.
Phase 2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for hepatitis b: Real-World trial of pradefovir underway
Disease control OngoingThis study is a multicenter, ambidirectional cohort real-world study initiated by the First Affiliated Hospital of Zhengzhou University, aiming to evaluate the efficacy and safety of Pradefovir Mesylate Tablets in the treatment of chronic hepatitis B (CHB).
Sponsor: Juan Li • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Scientists create personalized antibodies to attack stage IV cancer
Disease control By invitation onlyThe purpose of this research is to study the safety and effectiveness of investigational antibodies attacking certain areas on the surface of cancer cells so that the body can kill the cancer cells. The antibodies will be made in a laboratory from cells taken from each subject's …
Phase 1 • Sponsor: Moonshot Antibodies • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a new pill tame tough eczema? a large trial aims to find out
Disease control Recruiting nowThis clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study
Phase 3 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New hope for bladder cancer patients who can't have standard chemo
Disease control Recruiting nowThis phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based therapy. Cisplatin-based therapy is the standard of care for patie…
Phase 2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a simple vitamin cut Post-Transplant infections?
Disease control CompletedLiver transplantation (LT) remains the ultimate option to cure intractable end stage liver disease. Vitamin D deficiency is very common in these subsets of patients. Vitamin D is involved in calcium metabolism and bone mineralization, regulation of cytokines, immunomodulation, ce…
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New injection could help shed pounds in obesity trial
Disease control OngoingThis is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study in adult obese/overweight subjects in China to evaluate the efficacy and safety of GZR18 Injection in the subjects.
Phase 3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a second chemo drug slow prostate cancer growth?
Disease control Recruiting nowThe usual approach for most patients who are not in a study is treatment with docetaxel. This study is being done to answer the following question: Can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual approach? This study is being done…
Phase 3 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Art therapy meets oncology: could mandala coloring boost cancer Patients' well-being?
Symptom relief CompletedCancer is one of the most significant global health issues of our time. Chemotherapy, one of the methods used to treat cancer, not only treats the disease but also causes numerous physiological and psychological side effects that adversely affect quality of life. It has been repo…
Sponsor: Istanbul Medeniyet University • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New targeted drug SYS6043 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowPhase I/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors This study is a first-in-human phase I/II, multicenter, open-label, dose-escalation trial with PK expansion and cohort expansion, designed to evaluate the safety, tolerability, pharmacokinet…
Phase 1/2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC